Research field (6)：
Clinical pharmacy
, Pharmaceuticals - chemistry and drug development
, Pharmacology
, Pharmaceuticals - health and biochemistry
, Biomaterials
, Biomedical engineering
Research keywords (8)：
蛋白質工学
, プロテオミクス
, 薬物送達法
, 毒性学
, NanoTox
, Drug Therapeutics
, Biopharmaceutics
, Drug Delivery System
Research theme for competitive and other funds (39)：
2021 - 2024 マイクロプラスチックのリスク評価基盤の構築
2014 - 2019 Development of a new diagnostic method for heart failure in collaboration with drug engineers
2015 - 2017 Challenge to develop safety and effective nano-carriers for contributing to creation of mucosal vaccine
2013 - 2015 Approach to develop a dynamics control technology of nanomaterial for oral nano-vaccine carrier
2011 - 2012 Development of transcutaneous vaccine with efficacy and safety for the overcoming infectious diseases
2009 - 2012 The creation and safety assessment of cytokine adjuvant and nano-carrier for mucosal vaccine
2008 - 2009 An organelle targeting system as a next generation technology for drug development
Health effects of fine particle exposure on vulnerable generations. BIO Clinica. 2022. 37. 1. 59-63
松下俊介, 橘敬祐, 日下部哲也, 日下部哲也, 堤康央, 近藤昌夫. Regulatory Considerations of Conditional Approval for Balancing Pre-market and Post-market Evaluations to Achieve Early Patient Access to Medical Products in Japan. レギュラトリーサイエンス学会誌. 2021. 11. 2
庄真喜子, 橘敬祐, 原田和生, 平田收正, 堤康央, 國澤純, 國澤純, 國澤純, 國澤純, 國澤純, et al. Current situation and challenges of a regulatory concept of pharmacokinetics focusing on microbiome. 腸内細菌学雑誌. 2021. 35. 2
